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IN the early years ofthe nineteenth century, advances in chemistry led to the isolation
of active constituents from crude drugs. The isolation of the alkaloids in particular
was an important event in the development ofpharmacology. Their purity indicated
the advances being made in the chemistry oforganic materials, and the determination
ofdoses and descriptions oftheir properties reflect the growing use ofexperiment to
determine the action of substances on the animal body. In therapeutics, however,
they were not new: morphine was used where opium had been used before; a dose of
quinine replaced an infusion ofcinchona. To examine developments in experimental
pharmacology in relation to therapeutics and the thinking behind acceptance of a
new remedy in this period, it is ofgreater value to study hydrocyanic acid, the pure,
toxic, chemical substance which entered medicine at the same time as the alkaloids
and, with them, formed the group designated by Magendie in 1821 as nouveaux
medicaments.
Legends and stories of sudden death as a result of poisoning suggest that hydro-
cyanic acid has been available to assassins since earliest times, probably in the form
of aromatic preparations of peach and almond. In the early materia medica there
were a number of preparations containing hydrocyanic acid, amongst them cherry-
laurel water prepared by distilling the leaves ofPrunus laurocerasus, L., an evergreen
shrub containing the glucoside Prulaurasin which decomposes on distillation to
benzaldehyde and hydrocyanic acid (about 0.1 per cent). It was an investigation into
the toxicity ofthis preparation that opened the modem history ofthe pharmacology
ofthe acid.
In 1731, Thomas Maddem (died c. 1737), lecturer in anatomy and surgery in
Trinity College, Dublin, published the results of an investigation into the effects of
cherry-laurel water, which, used as a flavouring additive to brandy, had caused the
death of two Dublin women.' Maddern's experiments were on dogs, and he showed
that reaction varied with dose: small doses caused convulsions; larger doses brought
about paralysis and rapid death. In one experiment, he described the blood as being
of a 'very bright florid colour' and he was probably observing oxygenated venous
blood. Maddern opposed the opinion that the substance caused inflammation ofthe
stomach and intestines. The colour of these organs, resulting from the high colour
of the blood, lent support to this common explanation of the action ofpoisons, but
he observed that some ofthe animals reoovered too quickly for stomach inflammation
to be the cause oftheir condition. These experiments were repeated in 1731 by Crom-
well Mortimer (d. 1752), acting Secretary to the Royal Society of London.2 He also
commented on the colour of the blood and, finding clots in the veins and ventricles
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of the heart, suggested that the substance coagulated the blood so that it could not
pass the lungs and brain. A further confirmation ofthe poisonous nature ofcherry-
laurel appeared in 1737 as aresult ofsomeexperiments carriedoutunderthedirection
ofAbraham Vater (1684-1751).3
The next to take up the study was an English physician, Browne Langrish (d. 1759),
whowaslessconcernedwithtoxicitythanwithmodeofactionandpossibletherapeutic
effects ofsmall doses.4 His studies, reported in 1746, are anearly example ofa quanti-
tative approach totheelucidation ofapharmacological problem. Hebeganbymaking
a standard preparation using a method adopted by Mortimer. He took a peck of
leaves, weighed them carefully ('lest I might be deceived by different measure in
future Tryalls'), mixed them with three gallons of water, distilled and collected two
quarts of the distillate. To confirm that this sample had the same strength (i.e.
toxicity) as those ofthe earlier workers, he gave a dose offour fluid ounces to a large
dog, which died in convulsions within seconds. This sudden effect was attributed to
the action of the substance on the nerves and animal spirits, the action being too
rapid to be explained in any other way.
Langrish found more to interest him when he began to observe the results of
administering small doses. A daily dose was administered to a dog over a month,
then doubled over a further period. During the course of the experiments the pulse
rate increased, and at the end the blood was described as 'extremely florid and
beautiful ... the Coagulum ... as vivid as possible'. The subject remained apparently
healthy and even grew fat so that the author concluded the dose to be beneficial,
explaining its action as being the result ofits ability to thin the blood and so increase
the circulation. In another experiment, increasing doses of fresh leaves were ad-
ministered in food and an attempt made to assess the action of the substance by
allowing a known volume ofblood to coagulate, then weighing the separated serum.
Over a period of four months, during which time the dose was increased to two
ounces, an increase in the weight of separated serum was observed and this result
confirmed Langrish inhis opinion thatthepnrnciplesintheleaves 'thinned' the blood.
The supposed attenuation ofthe blood was attributed to alterations brought about
in the cohesion of its particles and Langrish believed he could pursue the matter
further by attempting to measure the resistance of the blood clot which is formed
after the sample of blood is allowed to stand for twenty-four hours. The technique
used was to take a glass tube, one-third ofan inch in diameter, with a closed 'obtuse'
point about the size of a pea. This was laid on the clot and the mercury poured into
the tube until the point penetrated the mass; the height of the column of mercury
was taken to be proportional to the resistance ofthe clot. In the experiment, which
was carried out on a sick horse, he found that the resistance ofthe clot was reduced
as the dose ofcherry-laurel increased. This was taken as further confirmation ofthe
attenuating effects ofthe preparation on the blood.
There are a number of interesting features in this investigation. First, Langrish
appreciated the value of animal experiments at a time when such experiments were
widely suspected as having little comparative value. Second, he realized that, in the
investigation of a reported poison, the effects of small doses should be investigated
aswell aslargertoxicdoses. (Laterin thecentury,Witheringredeemedthetherapeutic
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reputation of digitalis by using small doses). Third,, Langrish used quantitative
techniques to study physiological changes. These features, however, are of interest
only in relation to the history of experimental pharmacology; the work itself had
nothing to contribute to therapeutics. The peculiar effects of cherry-laurel upon the
blood, in particular the 'improved' colour, were misinterpreted by Langrish as being
ofa tonic and beneficial nature and led him to recommend the administration ofthe
water in toxic and near-toxic doses. Little notice, however, was taken ofthese recom-
mendations. At the time of the publication of Langrish's experiments, the evidence
of toxicity of the preparation had already brought it into disrepute. Not only was
cherry-laurel condemned, but also preparations of a similar nature. The revision
committee of the London pharmacopoeia of 1746 refused to admit Aqua cerasorum
nigrorum (black-cherry water), a common remedy for convulsive fits in children,
because experiments on animals had shown it to have an effect similar to that of
cherry-laurel. It was therefore considered too dangerous for children, especially in
thehands oftheirunskilled nurses.5 The Edinburgh College deleted the same prepara-
tion from its pharmacopoeia in 1756.
William Cullen in 1789 described the Aqua laurocerasi as a sedative of the most
powerful kind but was critical of its use in medicine.6 He rejected the opinions of
Langrish and also the belief that it was useful in the cure of pulmonary conditions.
At this time, a number ofphysicians in Europe were using it to treat chest complaints
where its transitory sedative action had the effect of reducing persistent coughing.
This had led to the claim, which Cullen rejected as having no reasonable basis, that
thepreparation curedphthisispulmonalis. Inview ofthe subsequent history ofhydro-
cyanic acid, it is interesting to note that Cullen continued to regard cherry-laurel as
a potential remedy: 'That a matter ofsuch power in changing the state ofthe animal
economy should, in certain circumstances, prove a medicine, we can have no doubt;
but we have not yet learned to what circumstance ofdisease it is peculiarly adapted'.
Thus it was that a preparation having a distinct physiological action on the body
was rejected from medicine, partly on the lack of a reasonable basis for its use in
therapy, but more particularly for the very obvious hazards attendant upon its use.
This was not merely because the water was toxic (there were many poisonous sub-
stancesinthemateriamedica), butbecauseitwasavariable, andtherefore adangerous
preparation. It is probable that the death of the two women which initiated the
investigation of the preparation was caused by a sample accidentally more potent
than that used before. Later, when hydrocyanic acid was introduced into medicine,
although of greater toxicity than cherry-laurel water, the problem did not exist
because it was a pure substance and the dose could be controlled by careful dilution.
When in 1779 the Italian scientist, Felice Fontana (1730-1805), began to study
cherry-laurel water, it was not as a medicament but as a poison.7 Fontana, who had
extensively studied viper venom and the American (curare) arrow poisons, began by
observing the effects ofthe water on rabbits and guinea pigs. His results were contra-
dictory and no relation could be established between dose, route of administration
andphysiological action-anotherresultofthevariability ofthepreparation. Fontana,
who, in his earlier studies, had been accustomed to working with small doses ofpure,
highly active poisons, resolved to attempt theisolation ofthe toxicprinciple incherry-
307Melvin P. Earles
laurel. To do this, he distilled the leaves with water and collected the distillate from
which an oil separated; the aqueous portion was then redistilled to obtain another
oil and an aqueous fraction which was distilled yet again. The residues, oils and
aqueous fractions were each administered to animals to observe their effects and
one hundred and thirty-nine tests were made using pigeons, guinea pigs, rabbits
and frogs. All these preparations, however, proved to be toxic and there was no
evidence that the toxic principle had been isolated or even concentrated. Fontana
had failed in his attempt to isolate the toxic principle of cherry-laurel but, by
a coincidence, the material he was seeking, was discovered shortly afterwards by
the Swedish apothecary chemist, Carl Wilhelm Scheele (1742-1786).8 In the course
ofhis study ofprussian blue, Scheele heated yellow prussiate ofpotash with sulphuric
acid and obtained a dilute acid. The solution had a characteristic smell, and Scheele
described it as having a slightly sweet taste-he was obviously unaware ofthe toxicity
of the new substance and was fortunate that it had not been isolated in a more con-
centrated form. He called the substance the 'colouring principle', and shortly after-
wards Guyton de Morveau gave it the more familiar name of prussic acid.9 The
relationship between this acid and known toxic vegetable materials was established
about 1800 when a German pharmacist named Bohm, observing a similarity between
the odour of the acid and distilled water of bitter almonds, used almond water to
prepare prussian blue.10 Two years later another pharmacist, Johann Christian Karl
Schrader (1762-1826) of Berlin, demonstrated the presence of the acid, which he
called 'blausaure', in cherry-laurel as well as in bitter almonds and peach.11 In his
experiments he treated the distillates with lime, added iron sulphate and then acidified
the mixture to obtain prussian blue. He put small birds into containers with the
acid and the manner of their death convinced him that it was the toxic principle of
cherry-laurel and bitter almonds. Shortly after this the acid was discovered in other
vegetable materials by Vauquelin and Bergeman.12
It was not long before the extreme toxicity of the newly discovered hydrocyanic
acid was clearly and unequivocably demonstrated. In 1805, Carl Friedrich Emmert
(d. 1834) published his experiments on dogs which showed it to be a rapid and
dangerous poison.13 In 1814, it was reported that the vapour killed rabbits, cats and
dogs within seconds14 and shortly afterwards Francois Magendie (1783-1855)
described the pure acid as the quickest acting substance known: an animal injected
with it died 'comme s'ileutt et frappe d'un boulet ou de lafoudre'.15
The introduction of hydrocyanic acid in a diluted form into the materia medica
was surprisingly rapid and quiteundeterred by the proven toxicity ofthe concentrated
acid. It began with the followers ofBrunonism and, in their case, developed directly
from the medicinal use of cherry-laurel water. The Brunonists, not averse to heroic
treatments, were in the habit ofprescribing cherry-laurel for cases ofwhat they called
'sthenic diseases' or diseases ofhigh excitement. One ofthem, Siro Borda (1761-1824),
a professor at Pavia, recommended a dilution ofpure hydrocyanic acid after Schrader
discovered its presence in cherry-laurel. This fact was reported by Luigi Brugnatelli
(1761-1818), whowent on to describe the acid as an anti-excitant and anthelmintic.16
The first recorded use of the acid for pulmonary complaints was by Valerino Luigi
Brera (1772-1840), who, in 1809, administered it to a female patient suffering from
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pneumonia." The major influence, however, in the introduction of the acid into
medicine for treatment of pulmonary conditions was that of Francois Magendie,
who, in 1817, published amemoironthesubject underthetitle, Mimoire sur l'emploi
de l'acide prussique dans le traitement de plusieurs maladies depoitrine, et particu-
lierement dans la phthisie pulmonaire.18
Thismemoiris ofparticularinterestto thehistory ofclinicalpharmacology because
it illustrates an early scientific approach to the therapeutic use ofanewpurechemical
substance. Magendie, in his experiments with strychnine arrow poisons in 180919
had clearly demonstrated the importance and scientific value of carefully planned
systematic animal experiments to determine the mode ofaction and sites ofaction of
poisons. Inthepaperonhydrocyanicacid, heexpressesthebeliefthatsuchexperiments
can advance therapy.
Physiological experiments, which are so important to the theory of medicine, are no less im-
portant to the practice and application ofthat science. They reveal the true value of substances
whose long use in medicine has been based only upon hypothetical principles and yield more
information on the mode of action of the really active substances so that it becomes easier to
vary their effects and to remedy their disadvantages. Their greatest advantage is to assist the
physician in the discovery of new medicaments either from amongst substances long known
but not used in medicine or from the many simple and compound chemicals which are the
dailydiscovery ofmoden chemistry andwhich, ifsubjected to thenew methods ofexamination,
may become particularly valuable to science and mankind.
The observation on which Magendie based his therapeutic measures was that
hydrocyanic acid apparently destroyed the sensibility and contractibility without
affecting the respiration and circulation. These observations were substantially
correct; the cyanide ion in low concentrations stimulates respiration and its effects
are compared by some authors with a transient functional decerebration. Magendie's
therapeutic deductions from these physiological observations were recorded as
follows: 'This property of extinguishing the general sensibility without ostensible
injury to the respiration and circulation . . . induced me first to believe that the
prussic acid might be advantageously used in cases where the disease seemed to owe
its origin to a vicious augmentation of sensibility.' Such a condition was persistent
nervous and chronic cough, and Magendie records a number of cases where the
diluted acid had been used with success. He extended treatment to cases with con-
sumption and, in a case where the disease was in the incipient stage, he considered
some improvement to have taken place. From the physiological observations and
case histories, Magendie drew a number of conclusions which provided a guide to
the use ofthe new medicament. He observed that the dilute acid is ofbenefit in cases
ofchronic or nervous cough. He recommended it as a useful palliative in tuberculosis
and suggested that on further study it may prove to be curative for the disease in its
early stages. He made it quite clear that on the evidence the pure acid was far too
toxic for use in medicine and observed that in cases oftuberculosis where the disease
was in an advanced stage even the dilute acid could be injurious. Obviously with so
dangerous a substance careful standardization and dose was important. In the case
studies for the 1817 memoir, Magendie had used Scheele's acid, but finding its
strength to be variable, turned to a purer form prepared after the manner of Gay-
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Lussac, who decomposed prussiate of mercury with hydrochloric acid. Later, in his
widely read Formulaire pour la PrJparation et l'Emploi de Nouveaux Midicamens
(Paris, 1821), Magendie recommended a preparation which he called 'medicinal
prussic acid' composed ofone part ofGay-Lussac acid and six parts ofwater.
This carefully reasoned monograph with its precise conclusions was one of the
first to include evidence of animal experiments in support of clinical findings and
was directly responsible forthe introduction ofthe acid into official French pharmacy
and medicine. It was included in an appendix to the Codex medicamentarius sive
Pharmacopoeia Gailica, published in 1818 and the first pharmacopoeia to be official
for the whole of France. There it appeared under the title Acidum Hydrocyanicum,
the latinized version of the new name given to it after Gay-Lussac's study of the
radical cyanogen. There it was stated that it was necessary to include the acid because
so many doctors, following Magendie's observations, were prescribing it for their
patients. The admission of the acid into the French pharmacopoeia probably led to
its inclusion in the first UnitedStatesPharmacopoeia in 1820.
Some time was to elapse before hydrocyanic acid was admitted into the official
British pharmacopoeias. It was first brought to the notice of English physicians by
the much-travelled Augustus Bozzi Granville (1783-1872), who had learned of the
effects of laurel water and prussic acid when he studied under Borda and Brera in
Pavia.20 Little notice was taken ofhis first paper in 181521 so, in 1818, he published a
translation of Magendie's memoir.22 A year later, he produced his An historical and
practical treatise on the internal use of the hydrocyanic acid, which reappeared in
1820 in a greatly enlarged second edition. In it, he reported on a number of case
histories where the acid had been used for a variety of nervous and pulmonary con-
ditions and gave a review of the methods of preparation. He took a proprietary
attitude to the new medicament, claiming that his writings on the subject had so
impressed doctors and laymen that he was embarrassed by the demands made upon
his services.
The sale of the acid in London in 1820 provides evidence that it was being fairly
extensively used there. It is reported by Granville that nine quarts ofthe preparation
was sold at Apothecaries' Hall over a period of nine months, and another chemist
recorded the disposal of forty pints over a similar period.23 It was being prescribed
at that time in St. Thomas's hospital, andit was there thatJohn Elliotson (1791-1868)
found a new use for it when a dose of the diluted acid, prescribed for a pulmonary
case, was administered by mistake to a patient suffering from 'violent spasms and
flatulence of the stomach'.24 The patient derived temporary relief, and henceforth,
on Elliotson's recommendation, the acid was prescribed for treatment ofgastrodynia,
dyspepsia and other stomach conditions where pain was experienced.
In spite of the use of the dilute acid in British practice, the compilers of the
PharmacopoeiaLondinensis, who only accepted new substances receiving the approba-
tion of a majority of the Committee, did not include the preparation in the 1824
edition. There were, of course, reasonable grounds for opposition to this substance.
The toxic properties ofcherry-laurel and similar preparations had led to their deletion
from medicine, and British physicians had no reason to be greatly influenced in
favour of a substance recommended by the followers of Brunonism. They were
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aware that it had been included in the French pharmacopoeia (in an appendix which
also included morphine), but the main text of that work was unlikely to impress
them, including as it did such items as frogs, vipers and millipedes, all ofwhich had
long been deleted from the London pharmacopoeia. Caution was expressed by
Thomas Cox in a commentary in his translation ofthe 1824 London pharmacopoeia:
' .... since the first introduction of hydrocyanic acid, few diseases occur in which
practitioners have not employed it. Although we are unable to decide the precise
condition of the body, or states of disease fit for the remedy, we cannot doubt its
activity, something further must be known before we prescribe it'.25
Caution in the official recognition ofa new drug is to be recommended but when a
drug is already in use and is of a highly active nature, it is in the interests of safety
that standards ofstrength and dose be established as soon as possible. In this respect
hydrocyanic acid can be said to have exposed a major problem facing compilers of
pharmacopoeias in the days before pharmacological testing was developed and when
judgement relied solely upon the habits and observations of general practice. The
shortcomings of the London pharmacopoeia in this particular instance were com-
pensated by commentaries and translations of the pharmacopoeia. Thomas Cox, in
an appendix to his translation, gave information concerning preparation and usage
and toxicity ofthe acid, although, as we have seen, he advised caution in its use and
accused Granville ofoverratingits value. Samuel Frederick Gray, inhis supplement to
the new pharmacopoeia,' gave information concerning the preparations of the acid
in the French formulary. In the preface, Gray criticized the methods of selection of
the London College and commented that prussic acid and the like, even ifonly used
by a minority of physicians, require 'an uniformity of preparation to be speedily
instituted'. He forecast the institution of the modern pharmacopoeial addenda when
he added that one should not wait for a new edition ofthe pharmacopoeia to regulate
the strength and preparations of new drugs.
A preparation ofhydrocyanic acid in the form of a two per cent dilution prepared
from ferrocyanide of potash and sulphuric acid was eventually introduced into the
Pharmacopoeia Londinensis in 1836. This led, in time, to the reintroduction of Aqua
laurocerasis, which appeared in the first British Pharmacopoeia of 1864. Thomas
Castle and Richard Phillips in their translations of the 1836 pharmacopoeia both
describe the acid as a sedative and antispasmodic." Pockets ofresistance to the drug
remained ('commonly used for suicide and is fit for little else', wrote Collier in
183728), but in general it was accepted as a useful item ofthe materia medica. In the
years that followed, distinguished teachers added their support for its use. A. T.
Thomson in 1835 recommended it as a palliative in cough, and described it as a
'sheet anchor ofthe practitioner' in the treatment of'hooping cough'.2' R. Christison
in 1842 labelled it as calmative, anodyne, antispasmodic and noted that in his own
practice its effects in dyspepsia were unequivocal." J. Pereira in 1850 expressed his
doubts concerning the value of the acid as a cure for pulmonary conditions but
recommended it as a sedative, particularly for gastrodynia.31
The importance of a medicinal substance must be measured against the other
materials available at the time. The sedantia of the early nineteenth century included
tobacco, aconite, hemlock, colchicum and blood-letting. Compared with these,
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hydrocyanic acid, properly diluted and dispensed, was an effective remedy and by
far the most efficient alternative to the narcotic opium. Its rapid sedative action,
even though ofa transitory nature, was a useful medicament to the physician. It was
soon discovered that it lacked the curative powers claimed for it, but as a palliative
giving relief to coughing and gastric pain it was welcome. Its decline began with the
introduction of new, more efficient sedatives, e.g. the bromides and chloral, in the
latter half of the nineteenth century, although it retained its place long after these
substances were admitted to the pharmacopoeias. In time, its toxicity became once
more a dominant idea in the minds ofphysicians and finally, with the advent of the
barbiturates and other synthetics, its period of usefulness was over. In 1918, A. R.
Cushny, in his Textbook ofPharmacology andTherapeutics (7th edition), commented
that prussic acid might be eliminated from therapeutics without loss. The Americans
deleted itfrom theirpharmacopoeia in 1925 and the French followed in 1937. Because
of delays in the publication of the pharmacopoeia, its official life was prolonged in
Britain until 1948.
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News, Notes and Queries
SIXTH HUNDREDTH ANNIVERSARY OF THE FOUNDATION
OF THE FIRST UNIVERSITY OF HUNGARY
IN 1367 King Louis d'Anjou (1342-1382) founded at P6cs or Fiinfkirchen (in Latin,
Quinque Ecclesiae) the first University of Hungary. It was the first centre of higher
education to be established in the south-east part ofEurope, and its foundation was a
sign ofthe cultural development ofHungary, then a great political power in Europe.
In 1345 King Louis wrote to Pope Clement VI, commenting on the difficulty of
obtaining a sufficient number of counsellors trained in the humanities. Although
talented students were sent to the Italian universities, especially to the universities
of Bologna and Padua, the expense was great, and the time necessary for the com-
pletion of their studies too long. King Louis therefore decided to found a
University in his own country where Hungarian, Croatian, and Dalmatian students
could be educated together. In 1360 he wrote to the Duke of the Carrara family in
whose territory the University ofPadua was situated at that time, to ask him to send
the Professor of Humanities, Bartolomeo Piacenti, to organize the school3 on the
model ofthe University ofPadua. ButBartolomeo Piacenticould not come. Afterlong
discussions Galvano di Bologna (known also as Galvano de Bettini),3 Professor of
Roman Law and Saraceno di Padova (known also as Giovanni Saraceno), an
apothecary and presumably a physician also, came in the year 1367 from Padua to
Hungary, where, with the help of King Louis and Wilhelm von Bergzabern, Bishop
of Pecs, the new humanistic university was organized. Bishop Wilhelm was a native
ofPfalz, Germany, and was the son ofHenrik ofBergzabern. He had had an excellent
education, and by the year 1357 he was a high ecclesiastical dignitary and privy
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